SNAI2 and colorectal carcinoma: Moreover, high SLUG expression is associated with poor clinical outcomes in human gastric cancer [14], esophageal squamous cell carcinoma [15, 16], colorectal carcinoma [17], lung adenocarcinoma [18], and prostate cancer [19].